Curing disease, growing organs, and even teaching organoids to play a computer game are sending seismic waves of hope within the research community as the potential increases exponentially.

It is still a very experimental procedure, but it likely will be improved rapidly in the coming years and may become the standard approach...

The FDA approves Aduhelm for the treatment of early Alzheimer's disease. Aduhelm targets brain plaque formation to slow the rate of cognitive decline.

The drip, drip, drip of innovation might just be a myth. Change commonly occurs as a punctuated reality that’s a function of converging events...